A comprehensive nationwide registry study of noncommunicable disease comorbidities and death in cancer patients in Norway—the NCDNOR project
Authors:
- Simon LergenmullerSLSimon Lergenmuller
- Trude Eid RobsahmTRTrude Eid Robsahm
- Yngvar NilssenYNYngvar Nilssen
- Knut Eirik DaleneKDKnut Eirik Dalene
- Wenche NystadWNWenche Nystad
- Haakon E. MeyerHMHaakon E. Meyer
- Hein StigumHSHein Stigum
- Lars J. KjerpesethLKLars J. Kjerpeseth
- Inger AriansenIAInger Ariansen
- Inger Kristin LarsenILInger Kristin Larsen
Open Access
- 28 February 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Noncommunicable disease (NCD) comorbidities are common in cancer patients due to shared risk factors, but few studies have mapped their occurrence across cancer types using detailed national data. In this nationwide cohort study, we used data from Norwegian mandatory health registries to comprehensively describe NCD comorbidities at and after cancer diagnosis of 19 cancers. We included 269,956 adults registered with a first cancer in the Cancer Registry of Norway 2009–2019. Comorbidities included second cancers, cardiovascular diseases (CVDs), chronic obstructive pulmonary disease, diabetes and mental health disorders (MDs). We used intersection diagrams to examine NCD comorbidity patterns at first cancer diagnosis, and multi-state models to estimate five-year post-cancer probabilities of NCD comorbidities and death. We also provide a publicly available online application [ https://ncdapp.onrender.com/ ] with additional results and details. Comorbidity prevalence at cancer diagnosis ranged from 35% (skin cancer) to 83% (lung cancer). CVD was most prevalent, usually co-occurring with MDs or diabetes. Lowest prevalences were found for younger patients and women. Conditioning on surviving five years, comorbidity probability exceeded 50% in all sites. Our findings show substantial comorbidity burden in cancer patients, varying by cancer site, age, and sex. Knowledge of these patterns could improve NCD prevention, treatment and surveillance.Keywords
Funding Information
- Norwegian Institute of Public Health
This publication has 36 references indexed in Scilit:
- A Systematic Review of Trajectories of Clinically Relevant Distress Amongst Adults with Cancer: Course and PredictorsJournal of Clinical Psychology in Medical Settings, 2024
- Clustering and trajectories of key noncommunicable disease risk factors in Norway: the NCDNOR projectScientific Reports, 2023
- The prevalence of chronic conditions in patients diagnosed with one of 29 common and rarer cancers: A cross-sectional study using primary care dataCancer Epidemiology, 2020
- Comorbid depression in medical diseasesNature Reviews Disease Primers, 2020
- Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based studyThe Lancet Oncology, 2019
- Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databasesThe Lancet, 2019
- Incidence of Diabetes After Cancer DevelopmentJAMA Oncology, 2018
- Regional variations in cancer survival: Impact of tumour stage, socioeconomic status, comorbidity and type of treatment in NorwayInternational Journal of Cancer, 2015
- Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancerCancer, 2013
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012